Generative artificial intelligence is moving from the margins of pharma into the center of how new medicines are imagined, built, and tested. Instead of tweaking existing compounds, these models can ...

Medra, a developer of AI-powered lab robots and scientists to advance drug discovery, raises $52M - SiliconANGLE ...

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

Phare Bio, a biotech social venture harnessing artificial intelligence to accelerate antibiotic discovery and development, and Basilea Pharmaceutica, a commercial-stage biopharmaceutical company ...

In a university lab, an AI system generated millions of novel molecules to fight drug-resistant infections. And they’re ...

This segment of drug discovery and development involves leveraging artificial intelligence to automate various tasks, including information collection, drug design, pre-clinical trial planning, and ...

Duke researchers have developed a new AI-powered approach to nanoparticle drug delivery design, which performed well in lab tests with cancer drugs Drugs that fight diseases work best when they reach ...

Researchers at Harvard Medical School developed a tool that uses artificial intelligence to accelerate drug discovery and development. The new technology, called PDGrapher, applies machine learning to ...

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...